Figures
close and return to previous windowPublished online: 25 July 2006, doi:10.1038/bioent910
The promise of the East: India and China as R&D options
Simon Goodall *, Bart Janssens **, Kim Wagner ***, John Wong , Wendy Woods & Michael Yeh*Simon Goodall is at The Boston Consulting Group, 355 South Grand Avenue, Suite 3200, 32nd Floor, Los Angeles, California 90071.
**Bart Janssens is at The Boston Consulting Group, 14th Floor, Nariman Bhavan, 227 Nariman Point, Mumbai 400.021, India.
***Kim Wagner is at The Boston Consulting Group, 430 Park Avenue, New York, New York 10022.
John Wong is at The Boston Consulting Group, 34th Floor Shell Tower, Times Square, Causeway Bay, Hong Kong China.
Wendy Woods and Michael Yeh are at The Boston Consulting Group, Exchange Place, 31st Floor, Boston, Massachusetts 02109. yeh.michael@bcg.com
Figure 1
|
|
|
Indian and Chinese partnering opportunities along the R&D value chain.
HTS/UHTS, high throughput screening / ultra-high throughput screening; SAR, structure-activity relationship; PKDM, pharmacokinetics and drug metabolism |
close and return to previous window